Guwahati Mail

Hidradenitis Suppurativa Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | AbbVie, Novartis, UCB Biopharma, Eli Lilly

Hidradenitis Suppurativa Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | AbbVie, Novartis, UCB Biopharma, Eli Lilly

The Key Hidradenitis Suppurativa Companies in the market include – Kymera Therapeutics, CSL Behring, Azora Therapeutics, Union Therapeutics, Eli Lilly and company, Boehringer Ingelheim, ACELYRIN, Incyte Corporation, InflaRx, Novartis, ChemoCentryx,

Read Full Article

Diabetes Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Eli Lilly and Company, Regor Pharma AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences

The Key Diabetes Companies in the market include – Eli Lilly and Company, Regor Pharmaceuticals Inc., AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova, Sparrow Pharmaceuticals, HighTide Biopharma Pty

Read Full Article

Type 2 Diabetes Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Ionis Pharma, Eli Lilly, Oramed Pharma, AstraZeneca, Novo Nordisk, Jiangsu

(Albany, New York) – September 24, 2026: (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Type 2 Diabetes pipeline constitutes 75+ key companies continuously working towards developing 80+

Read Full Article

Presbyopia Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | AbbVie, Orasis Pharma, Eyenovia, Glaukos Corp., Ocuphire Pharma, Novartis

The Key Presbyopia Companies in the market include – AbbVie, Orasis Pharmaceuticals, Eyenovia, Glaukos Corporation, Ocuphire Pharma, Inc., Novartis, Allergan, AbbVie, LENZ Therapeutics, Eyenovia, Visus Therapeutics, and others . The

Read Full Article

Respiratory Syncytial Virus Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2034 – DelveInsight | GSK, Merck, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi

The Key Respiratory Syncytial Virus Companies in the market include – GlaxoSmithKline, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharmaceuticals, ADMA Biologics, Enanta Pharmaceuticals, Merck Sharp & Dohme, Janssen

Read Full Article

Polycythemia Vera Market Size, Emerging Therapies, and Forecast Insights Through 2036 – DelveInsight | Protagonist Therapeutics, Italfarmaco, Imago BioSciences, Silence Therapeutics, Ionis Pharma

The Key Polycythemia Vera Companies in the market include – Protagonist Therapeutics, Italfarmaco, Imago BioSciences, Silence Therapeutics, Ionis Pharmaceutical, Perseus Proteomics, Protagonist Therapeutics, Inc., Novartis, PharmaEssentia, AOP Orphan Pharmaceuticals AG,

Read Full Article

Diabetic Nephropathy Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Helixmith, Lexicon Pharma, Glenmark Pharma, Regenacy Pharma, Praetego, Mitsubishi Tanabe

(Albany, New York) – September 24, 2026: As per DelveInsight’s assessment, globally, Diabetic Nephropathy pipeline constitutes 20+ key companies continuously working towards developing 25+ Diabetic Nephropathy treatment therapies, analysis of

Read Full Article

Prostate Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Telix Pharma, Merck, Orion Pharma, Exelixis, Ipsen Pharma, Takeda, Pfizer

(Albany, New York) – September 24, 2026: As per DelveInsight’s assessment, globally, Prostate Cancer pipeline constitutes 140+ key companies continuously working towards developing 150+ Prostate Cancer treatment therapies, analysis of

Read Full Article

Acute Respiratory Distress Syndrome Market to Witness Strong Growth and Significant Market Expansion by 2036 – DelveInsight | Veru, Athersys, Histocell, BioXcellerator, Altor BioScience, Nobel Pharma

The Key ARDS Companies in the market include – Light Chain Bio, Direct Biologics, Healios/Nobel Pharma, Mesoblast, Chrysalis BioTherapeutics, Athersys,

Read Full Article

Fortified Dairy Products Market Size to Reach $49.19 Billion by 2030 as Demand for Functional Micronutrients and Precision-Fermented Proteins Gains Momentum – Mordor Intelligence

Fortified Dairy Products Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the fortified

Read Full Article

Ulcerative Colitis Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Ulcerative Colitis Clinical Trial Analysis Report delivers important insights into ongoing research of 70+ pipeline Ulcerative Colitis Drugs, clinical

Read Full Article

Crohns’ Disease Clinical Trial Drug Development Pipeline Expands with Contributions from 90+ Key Companies | DelveInsight

The Crohns’ Disease Clinical trial analysis report delivers important insights into ongoing research of 90+ pipeline Crohns’ Disease Drugs, clinical

Read Full Article

Athlete’s Foot Market Poised for Growth as Awareness Increases and Advanced Antifungal Therapies Progress Through the Pipeline

Key Athlete’s Foot companies such as Bausch Health, Blueberry Therapeutics, and others. (Albany, New York) – September 24, 2026 – DelveInsight’s

Read Full Article

Atopic Dermatitis Market Poised for Growth as Targeted Therapies and JAK Inhibitors Expand Treatment Landscape

Key Atopic Dermatitis companies such as Roche, Eli Lilly and Company, Almirall, Chugai Pharmaceutical, Galderma, Maruho, AbbVie, Pfizer, LEO Pharma,

Read Full Article

Huntington’s Disease Market is Projected to Grow at 14% CAGR by 2036 Owing to Advancements in Gene and RNA-Based Therapies | DelveInsight

The market dynamics for Huntington’s Disease are witnessing significant growth driven by the advancements in gene and RNA-based therapies, rising

Read Full Article

Frontotemporal Dementia Market is Projected to Grow at 15% CAGR by 2036 Owing to Rising Disease Burden and Advancements in Gene-Based Therapies | DelveInsight

The market dynamics for Frontotemporal Dementia are witnessing significant growth driven by the rising prevalence of FTD, increasing disease awareness

Read Full Article

Esophageal Cancer Market is Projected to Grow at 6.0% CAGR by 2036 Owing to Rising Disease Burden and Advances in Immunotherapy and Targeted Therapies | DelveInsight

The market dynamics for Esophageal Cancer are witnessing steady growth driven by the rising disease burden and associated risk factors,

Read Full Article

Merkel Cell Carcinoma Incident Cases in the 7MM Projected to Rise from 9.5 Thousand in 2023 Through 2034Merkel Cell Carcinoma Epidemiology

MCC is a rare, aggressive neuroendocrine skin cancer that originates from Merkel cells, specialized mechanoreceptors located at the dermo-epidermal junction

Read Full Article

Cell and Gene Therapies in Rare Disorders Market to Expand as Regulatory Approvals and Pipeline Innovation Accelerate Adoption | DelveInsight

Cell and Gene Therapies in Rare Disorders market is undergoing significant transformation as advances in genetic medicine, increasing clinical development

Read Full Article

Mydriasis Market to Reach New Heights in Growth by 2034 | DelveInsight Predicts

This report provides detailed insights into the Mydriasis market, including revenue trends, prevalence, and the evolving treatment landscape. It highlights

Read Full Article

Recent Posts

Hidradenitis Suppurativa Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | AbbVie, Novartis, UCB Biopharma, Eli Lilly

Read Full Article

Categories